These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32302615)

  • 1. Pleiotropic effects of statins via interaction with the lipid bilayer: A combined approach.
    Penkauskas T; Zentelyte A; Ganpule S; Valincius G; Preta G
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183306. PubMed ID: 32302615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins.
    Murphy C; Deplazes E; Cranfield CG; Garcia A
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Statins on the Nanomechanical Properties of Supported Lipid Bilayers.
    Redondo-Morata L; Lea Sanford R; Andersen OS; Scheuring S
    Biophys J; 2016 Jul; 111(2):363-372. PubMed ID: 27463138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From fungus to pharmaceuticals--the chemistry of statins.
    McPherson PA
    Mini Rev Med Chem; 2012 Oct; 12(12):1250-60. PubMed ID: 22512563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of lipid-lowering therapies.
    Hu M; Tomlinson B
    Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of HMG-CoA Reductase: Current and Future Prospects.
    Singh N; Tamariz J; Chamorro G; Medina-Franco JL
    Mini Rev Med Chem; 2009 Oct; 9(11):1272-83. PubMed ID: 19929805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant].
    Stalenhoef AF; Stehouwer CD
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):308-10. PubMed ID: 10707739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
    Zhou Q; Liao JK
    Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of statin therapy on the progression of chronic kidney disease.
    Shah S; Paparello J; Danesh FR
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):187-95. PubMed ID: 15822054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelium-dependent effects of statins.
    Wolfrum S; Jensen KS; Liao JK
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):729-36. PubMed ID: 12615672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins: possibly more than just lowering of the lipid level].
    Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving LDL-C target levels: the role of statins.
    Lablanche JM
    Curr Med Res Opin; 2001; 16(4):285-95. PubMed ID: 11268713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins: the new aspirin?
    Veillard NR; Mach F
    Cell Mol Life Sci; 2002 Nov; 59(11):1771-86. PubMed ID: 12530513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pleiotropic effects of statins.
    Calabrò P; Yeh ET
    Curr Opin Cardiol; 2005 Nov; 20(6):541-6. PubMed ID: 16234628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial cardiovascular pleiotropic effects of statins.
    Davignon J
    Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: candidate mechanisms for anti-lipid deposition in blood vessels.
    Kumai T; Matsumoto N; Koitabashi Y; Takeba Y; Oonuma S; Sekine S; Tadokoro M; Kobayashi S
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):195-201. PubMed ID: 15974884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors.
    Kiener PA; Davis PM; Murray JL; Youssef S; Rankin BM; Kowala M
    Int Immunopharmacol; 2001 Jan; 1(1):105-18. PubMed ID: 11367508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.